{"input_url":"https://www.asbmb.org/asbmb-today/careers/070826/how-enzyme-chemistry-is-reshaping-peptide-drugs","gnews_decode":"https://www.asbmb.org/asbmb-today/careers/070826/how-enzyme-chemistry-is-reshaping-peptide-drugs","http_status":200,"final_url":"https://www.asbmb.org/asbmb-today/careers/070826/how-enzyme-chemistry-is-reshaping-peptide-drugs","html_length":82879,"trafilatura_result":"ok","text_length":8414,"text_preview":"How enzyme chemistry is reshaping peptide drugs\nPeptide drugs offer greater surface specificity than small molecules for therapeutic applications. Making them as stable in the body as small molecules remains a major challenge. Sethera Therapeutics, a peptide biotechnology company based in Salt Lake ","verdict":"OK"}